Furthermore, treatment with HMGB1 reduces insulin-induced Akt phosphorylation, hampers GLUT4 translocation from the cytoplasm to the cell membrane in response to insulin, and slows down glucose uptake in GCs from non-PCOS women [88]. This evidence concerns the gene AKT1 and polycystic ovary syndrome.